2. Erythrocytes copy
Page 1: Production of Red Blood Cells
Development Changes
As red blood cells (RBCs) mature:
They fill with hemoglobin to a concentration of about 34%.
The nucleus condenses and is eventually absorbed or extruded from the cell.
The endoplasmic reticulum is also reabsorbed.
At this stage, these cells are termed reticulocytes due to the remaining basophilic material, which includes remnants of the Golgi apparatus, mitochondria, and a few other cytoplasmic organelles.
Transition to Maturity
Reticulocytes enter the bloodstream from the bone marrow through a process called diapedesis.
The basophilic material fades within 1 to 2 days, leading to the final form as mature erythrocytes.
Reticulocytes represent less than 1% of all RBCs due to their short lifespan.
Page 2: Erythropoietin Regulates Red Blood Cell Production
Regulation of RBC Mass
The total mass of RBCs is tightly regulated to:
Ensure sufficient transport of oxygen from the lungs to tissues.
Prevent excessive numbers of cells that could block blood flow.
Page 3: Tissue Oxygenation and RBC Production
Oxygen Levels
Decreased oxygen transport to tissues typically triggers an increase in RBC production.
Page 4: Erythropoietin and Hypoxia
Erythropoietin as a Stimulus
Erythropoietin (EPO), a circulating hormone, is the primary stimulator for RBC production in hypoxic conditions.
It is a glycoprotein with a molecular weight around 34,000.
Without EPO, hypoxia has minimal effect on stimulating RBC production.
Page 5: Erythropoietin Production Location
Formation Sites
Approximately 90% of EPO is produced in the kidneys, with the remainder formed mainly in the liver.
Renal hypoxia elevates hypoxia-inducible factor-1 (HIF-1), which influences the transcription of EPO and other hypoxia-inducible genes, driving increased EPO synthesis.
Page 6: EPO Regulation Mechanism
Feedback Mechanism
Stimulus: Decreased blood oxygen levels.
Detection: Kidneys detect low O2, inhibiting EPO release through negative feedback.
EPO Release: Kidney cells release EPO into the bloodstream.
Effectors: EPO stimulates red bone marrow, increasing erythrocyte production.
Net Effect: Elevated erythrocyte numbers enhance blood O2 levels.
Page 7: EPO Binding and Effects
Interaction with EPO Receptor
EPO (ligand) binds to its receptor (EPOR) on the surface of immature erythroid cells, initiating a signal that leads to:
Increased cell division and maturation.
Augmented intestinal iron absorption and hemoglobin production.
More RBCs entering circulation.
Page 8: EPO Sensitivity
Varying EPO Sensitivity
EPO-responsive cells' sensitivity varies:
Some cells respond to low EPO levels; others require higher EPO levels.
Under stable erythropoiesis, only low EPO levels suffice, while higher EPO levels due to hypoxia mobilize a broader range of responsive cells.
Page 9: Hypoxia and Kidney Response
Nonrenal Stimuli
Hypoxic conditions in tissues other than the kidneys can stimulate erythropoietin secretion from the kidneys, suggesting nonrenal sensors may exist.
Factors like norepinephrine, epinephrine, and prostaglandins promote EPO production.
Removal or failure of both kidneys results in significant anemia due to insufficient EPO production from other tissues, primarily the liver.
Page 10: EPO Role in Bone Marrow
Timeframe and Effects
In response to hypoxia, EPO levels rise within minutes to hours and peak within 24 hours.
RBCs do not appear in the circulation immediately; it takes about 5 days post-EPO effect for mature cells to emerge.
EPO primarily stimulates the production of proerythroblasts from hematopoietic stem cells in the bone marrow.
It accelerates the cell's transition through the erythroblastic stages, enhancing RBC production rates.
Page 11: EPO and RBC Production Rate
EPO Impact on Production
In the absence of EPO, minimal RBCs are produced.
With high EPO levels in nutrient-rich conditions, RBC production can increase up to 10 times normal.
EPO's regulatory mechanism for RBC production is potent.
Page 12: Nutritional Influence on RBC Maturation
Importance of Nutrition
Erythropoietic cells in bone marrow are some of the fastest-growing in the body, heavily influenced by nutritional status.
Page 13: Essential Vitamins for Maturation
Key Nutrients
Vitamin B12 (Cyanocobalamin) and Folic Acid are crucial for RBC maturation as they are required for DNA synthesis.
Deficiencies in either vitamin lead to abnormal DNA synthesis, hinder nuclear maturation, and reduce cell division.
Page 14: Macrocyte Formation
Consequence of Vitamin Deficiency
Erythroblasts in vitamin-deficient conditions yield larger than normal RBCs, termed macrocytes.
Macrocytes have fragile membranes, leading to a reduced lifespan compared to typical erythrocytes.
Page 15: Pernicious Anemia
Absorption Failure of B12
Pernicious anemia is often due to failure in the gastrointestinal absorption of vitamin B12, often linked with atrophic gastric mucosa lacking intrinsic factor.
Page 16: Folic Acid Deficiency
Sources and Common Issues
Folic acid, present in green vegetables, fruits, and meats, is susceptible to destruction during cooking.
Absorption issues, as seen in conditions like sprue, complicate intake of both folic acid and vitamin B12.
Page 17: Factors Controlling Erythropoiesis
Categories of Influences
Erythropoiesis is controlled by three primary factors:
Hormonal
Dietary
Other factors that affect production.
Page 18: Life Span of RBCs
Circulation Duration
RBCs typically last about 120 days in circulation before undergoing destruction, primarily in the spleen and liver.
Page 19: RBC Functionality
RBC Composition
Although mature RBCs lack a nucleus, mitochondria, or endoplasmic reticulum, they retain cytoplasmic enzymes that facilitate glucose metabolism and the formation of ATP. These enzymes maintain:
Cell membrane pliability.
Membrane transport of ions.
Iron in hemoglobin as ferrous rather than ferric.
Prevention of protein oxidation in RBCs.
Page 20: Aging and Fragility of RBCs
Aging Process
Old RBCs experience declining metabolic activity, leading to increased fragility.
Fragile membranes can rupture when passing through narrow circulatory points.
Many RBCs self-destruct in the spleen during this passage.
Removal of the spleen results in an increased count of abnormal aged RBCs circulating in the blood.
Page 21: Blood Types and Transfusion
Page 22: Blood Antigens
Antigen Complexity
Human blood cells possess at least 30 common antigens and hundreds of rare antigens that can elicit antigen-antibody reactions.
The O-A-B system and the Rh system are most critical concerning transfusion reactions.
Page 23: A and B Antigens
Characteristics of Antigens
Type A and B antigens (agglutinogens) are complex oligosaccharides differing by terminal sugars.
An H gene encodes a transferase that forms H antigen.
Variations are presented in individuals:
Type A: has N-acetylgalactosamine.
Type B: has galactose.
Type AB: has both.
Type O: lacks both, retaining only H antigen.
Page 24: Agglutinogens and Reactions
Role in Transfusion
A and B antigens are often responsible for transfusion reactions due to agglutination properties.
Inheritance patterns can yield no antigen, one antigen, or both.
Page 25: Major O-A-B Blood Types
Classification
Blood types are categorized based on the presence of A and B agglutinogens:
Type O: absent both A and B.
Type A: present A only.
Type B: present B only.
Type AB: present both A and B.
Page 26: Agglutinin Development
Antibodies in Plasma
The absence of type A agglutinogens leads to the development of anti-A agglutinins; type B absence leads to anti-B agglutinins.
Type O individuals develop both anti-A and anti-B; type A develops anti-B, and type B develops anti-A; type AB has no agglutinins.
Page 27: Agglutinin Development by Age
Timeline of Development
At birth, agglutinin levels are nearly zero.
By 2 to 8 months, an infant begins producing agglutinins, peaking at 8 to 10 years before gradually declining.
Page 28: Origin of Agglutinins
Production Sources
Agglutinins are gamma globulins, produced by bone marrow and lymph nodes, similar to antibodies for other antigens.
Small amounts of A and B antigens from food and bacteria may trigger antibody production against non-present agglutinogens.
Page 29: Agglutination Mechanism
Reaction Process
When mismatched blood is mixed, anti-A or anti-B agglutinins react with corresponding RBC agglutinogens, causing RBC agglutination.
Agglutinins with multiple binding sites can link RBCs, causing clumping.
Page 30: Outcomes of Agglutination
Consequences of Clumping
Agglutinated cells can obstruct blood vessels within circulation.
Over time, agglutinated cells may undergo hemolysis; the released hemoglobin is converted to bilirubin.
Page 31: Universal Donors and Recipients
Type O and AB Characters
Type O blood (lacking A and B antigens) can transfuse to any blood type but should be administered carefully to limit plasma volume.
Type AB individuals can receive any type of blood due to the absence of agglutinins, making them universal recipients, albeit with plasma cautions.
Page 32: Precautions in Transfusion
Importance of Cross-Matching
Blood transfusions require matching to avoid reactions; emergency procedures may utilize universal donor principles but are dangerous without cross-matching.
Cross-matching involves mixing donor RBCs with recipient plasma to observe for agglutination.
Page 33: Acute Hemolysis Overview
Immediate Reactions
Mismatches can cause immediate hemolysis through complement activation and lysis processes.
Immediate reactions are less common than delayed ones and typically require specific antibodies called hemolysins.
Page 34: Blood Typing Process
Typing Procedures
Blood typing involves separating RBCs and mixing them with anti-A and anti-B agglutinins, observing for agglutination to identify blood types.
Page 35: Rh Blood Types Overview
Rh System Significance
Rh blood types are crucial along with O-A-B types; spontaneous Rh agglutinins are rare and typically result from prior exposure to Rh antigens.
Page 36: Rh Antigens
Variants of Rh Factors
Six primary types of Rh antigens (C, D, E, c, d, e); individuals have pairs of these antigens according to shared inheritance patterns.
Page 37: Rh Positive vs. Negative
Characteristics of Rh Blood
Type D is the prominent Rh antigen; Rh-positive individuals possess it while Rh-negative individuals do not.
Rh-negative individuals may react to other Rh antigens, albeit with milder severity.
Page 38: Immune Response to Rh
Sensitization Mechanics
When Rh-positive RBCs enter an Rh-negative individual, anti-Rh antibodies develop over 2-4 months, leading to potential sensitization after multiple exposures.
Page 39: Characteristics of Rh Reactions
Delayed Reactions
An Rh-negative individual may not experience immediate reactions after receiving Rh-positive blood, but delayed reactions can occur due to antibody buildup, leading to hemolysis by tissue macrophages.
Page 40: Erythroblastosis Fetalis Definition
Description
Erythroblastosis fetalis involves agglutination and destruction of fetal RBCs, presenting significant clinical concerns.
Page 41: Incidence in Newborns
Risk Factors
First pregnancies of Rh-negative mothers with Rh-positive babies typically show minimal risk; however, subsequent pregnancies increase the likelihood of erythroblastosis fetalis.
Page 42: Maternal Antibodies Impact
Effects on Fetus
Maternal anti-Rh antibodies can cross the placenta, agglutinating fetal blood and causing hemolysis, leading to jaundice from bilirubin release.
Page 43: Clinical Picture
Symptoms Presentation
Newborns with erythroblastosis may present with jaundice and severe anemia at birth, with maternal antibodies persisting for months causing ongoing RBC destruction.
Page 44: Rapid RBC Production
Disease Progression
The fetus's rapid RBC production (including immature cells) can lead to erythroblastosis fetalis; bilirubin-related brain damage may occur, raising concerns for kernicterus.
Page 45: Treatment Options
Blood Replacement Therapy
Treatment includes exchanging neonatal blood with Rh-negative blood, repeated as needed to manage bilirubin levels and reduce kernicterus risks.
Page 46: Prevention Strategies
Use of Rh Immunoglobulin
Rh immunoglobulin administration to Rh-negative mothers has significantly reduced erythroblastosis incidences since the 1970s, preventing sensitization by targeting D antigen exposure.
Page 47: Mechanisms of Action
Immunological Interference
The exact mechanism of Rh immunoglobulin is unclear; it inhibits B lymphocyte antibody production against Rh antigens and neutralizes Rh-positive fetal RBC antigens that enter the mother's circulation.
Page 48: Reaction Mechanism
Transfusion Risks
Mismatched blood transfusions generally lead to agglutination, although immediate reactions are limited due to dilution effects.
Page 49: Consequences of Hemolysis
Symptoms and Outcomes
Transfusion reactions lead to hemolysis, increased bilirubin levels resulting in jaundice if significant RBC destruction occurs.
Page 50: Kidney Failure Risks
Lethal Consequences
Transfusion reactions can cause acute kidney failure due to antigen-antibody reactions causing renal damage and systemic shock.
Page 51: Kidney Shutdown Mechanism
Factors Leading to Failure
Kidney failure from transfusion reactions results from:
Toxic substances from hemolysis causing vasoconstriction.
Loss of RBCs leading to circulatory shock.
Excess hemoglobin causing tubular obstruction and subsequent renal shutdown.